Sienna Increases European Presence Expanding into Finland with hTERT test
6 February 2020 ASX RELEASE Melbourne, Australia: Sienna Cancer Diagnostics Ltd (ASX:SDX) (“Sienna” or “the Company”) is pleased to announce the appointment of Immuno Diagnostic Oy as an exclusive distributor in Finland. The distribution agreement provides Immuno Diagnostic with the right…
Trajan’s hemaPEN® included on TGA’s ARTG as first blood microsampling device for use in Australia
7 February 2020 Trajan Scientific and Medical’s hemaPEN® device has been included on the Australian Register of Therapeutic Goods (ARTG). The device enables the volumetrically accurate collection and storage of four dried blood spot (DBS) samples remote to the…
Gut reaction: how immunity ramps up against incoming threats
30 January 2020 A new study has revealed how the gut’s protective mechanisms ramp up significantly with food intake, and at times of the day when mealtimes are anticipated based on regular eating habits. Professor Gabrielle Belz (left)…
On-shore commercial manufacture and wider subsidy for CAR T-Cell therapy
28 January 2020 Peter Mac welcomes today’s announcements that will enable Australia’s first on-shore commercial manufacture of CAR T-Cell therapy, and lead to wider subsidised access to this treatment. Cell Therapies Pty Ltd, a company situated at Peter…
CSIRO to support nation’s bushfire rebuild
29 January 2020 CSIRO, Australia’s national science agency, has welcomed its role in delivering practical resilience measures in relation to bushfires and climate change, as the country faces continued extreme fire weather in the future. Announced by Prime…
On-shore commercial manufacture and wider subsidy for CAR T Cell therapy
28 January 2020 Peter Mac welcomes today’s announcements that will enable Australia’s first on-shore commercial manufacture of CAR T-Cell therapy, and lead to wider subsidised access to this treatment. Cell Therapies Pty Ltd, a company situated at Peter…
Genetic drivers of myeloproliferative diseases revealed – WEHI
24 January 2020 Dr Melissa Call, Associate Professor Matthew Call, and Dr Jessica Bridgford led the study at the Walter and Eliza Hall Institute. Institute scientists have revealed seven new genetic mutations that cause myeloproliferative diseases – chronic…
One step closer to understanding cancer-fighting immune cells
23 January 2020 Researchers discover that protective immune cells are not created equally This article first appeared in Science in Public. Personalised treatment of cancers has moved one step closer, thanks to University of Melbourne researcher Dr Susan Christo. Increasingly,…
Melbourne start-up Navi Medical Technologies receives $400,000 through Accelerating Commercialisation grant to develop pediatric medical device
30 January 2020 Navi Medical Technologies, a Melbourne based start-up company with ambitions to help critically ill newborns, has recently been awarded $396,452 in funding according to a recent media announcement from The Hon Karen Andrews MP, the Minister for Industry, Science…
Melbourne – A Heartland City in a New Decade
30 January 2020 Poised for Rockstar status as a Science & Technology Biomedical cluster Every year the Global Innovation Index ranks the innovation performance of around 130 economies globally. The picture from the Global Innovation Index reflects that…
Adoption and Diffusion of Disruptive Technologies:The Case of 3D Printing in the Medical Device Industry
28 January 2020 Australia has hosted several innovations in the 3D printed medical device industry, however widespread adoption and diffusion is quite low. This two-year project, funded by RMIT University provides analysis of the industry, its stakeholders (i.e. surgeons, patients,…
Importance of acceptable use policy – IT Systems & Services
28 January 2020 An acceptable use policy (AUP) is a document stipulating constraints and practices that a user must agree to for access to a corporate network or the Internet. Many businesses and educational facilities require that employees…
